Overview
Please be advised that Clinical Hematology International is currently migrating onto a new platform (https://chi.scholasticahq.com/) and no longer accepting new submissions at Springer Nature. We kindly advise that you Contact Tetsuzan Benny Ron <tetsuzanbennyron@gmail.com> for new manuscript submission and other relevant issues.
Clinical Hematology International is the official journal of the International Academy for Clinical Hematology (IACH). The journal is published by Springer quarterly as an open access peer-reviewed journal. This journal aims to address all aspects related to clinical hematology research and education. The first issue of Clinical Hematology International was published March 1, 2019. The journal is an open access journal, i.e. all articles are immediately and permanently free to read, download, copy & distribute. The journal is published under the CC BY 4.0 user license which defines the permitted 3rd-party reuse of its articles. The journal follows the ethical publishing code of conduct as implemented by Springer without any interference from the IACH.
Publication in this journal is currently free of charge for Authors. All open access publication fees are currently subsidized (submission and publication fees) through an independent educational grant from the ASSOCIATION FOR TRAINING, EDUCATION, AND RESEARCH IN HEMATOLOGY, IMMUNOLOGY, AND TRANSPLANTATION (A.T.E.R.H.I.T).), a French non-profit research organization dedicated to the support of research in hematology (“association loi 1901”) founded and based at Hôpital Saint-Antoine, Sorbonne University, 184 rue du Faubourg Saint-Antoine, 75571 Paris, France. Note that this is a promotional offer which applies to all papers submitted before 31 December 2023.
The journal is not supported and does not receive any funding from any commercial entity, beside the academic support described above. Very stringent measures are implemented to ensure the total independence, unbiased nature, and integrity of the journal.
Journal metrics
The journal’s yearly average acceptance rate is 50%, the average period from submission to first decision is 24 days.
- Editors-in-Chief
-
- Mohamad Mohty,
- Arnon Nagler,
- Bipin Savani
- Submission to first decision (median)
- 8 days
- Downloads
- 71,339 (2023)
Societies and partnerships
Latest articles
Journal updates
-
About International Academy for Clinical Hematology
Learn more about International Academy for Clinical Hematology (IACH), its activities and Conflict of Interest policy.
-
Congratulations!
Clinical Hematology International has been successfully indexed in Scopus in January 2023
Journal information
- Electronic ISSN
- 2590-0048
- Abstracted and indexed in
-
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- DOAJ
- Dimensions
- EBSCO
- Google Scholar
- Naver
- OCLC WorldCat Discovery Service
- Portico
- ProQuest
- ProQuest-ExLibris Primo
- PubMedCentral
- SCOPUS
- TD Net Discovery Service
- Wanfang
- Copyright information